Glazer Capital reports 8.67% stake in Select Medical
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Glazer Capital, LLC and Paul J. Glazer report beneficial ownership of Select Medical Holdings Corporation common stock on an amended Schedule 13G. The reporting persons disclose beneficial ownership of 10,744,069 shares of common stock, representing 8.67% of the outstanding class.
They report 0 shares with sole voting or dispositive power and 10,744,069 shares with shared voting and shared dispositive power, held by funds and managed accounts for which Glazer Capital serves as investment manager. Mr. Glazer is managing member of Glazer Capital, and the filers state that the filing should not be construed as an admission of beneficial ownership under Section 13.
Key Figures
Key Terms
beneficial owner regulatory
investment manager financial
Schedule 13G regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Select Medical (SEM) is reported by Glazer Capital on this Schedule 13G/A?
Who are the reporting persons on this Select Medical (SEM) Schedule 13G/A?
Where are Glazer Capital and Paul J. Glazer based according to the SEM Schedule 13G/A?
AI-generated analysis. How Rhea-AI works. Not financial advice.